Format

Send to

Choose Destination
Prim Care. 2015 Jun;42(2):189-93. doi: 10.1016/j.pop.2015.01.001. Epub 2015 Mar 20.

Guillain-Barré syndrome.

Author information

1
Department of Medical Education, Midtown Medical Center, Columbus Regional Healthcare, 1900 10th Avenue, Suite 100, Columbus, GA 31901, USA. Electronic address: vibhuti.ansar@columbusregional.com.
2
2300-A Manchester Expressway, Suite 201, Columbus, GA 31903, USA.

Abstract

Guillain-Barré syndrome and its clinical variants are a group of rapidly progressing, potentially debilitating neurologic disorders that may have significant morbidity/mortality if left unrecognized or untreated. The most common symptoms include ascending limb weakness and paralysis, which may progress to respiratory failure. Diagnosis is made clinically with laboratory testing. Several treatment options exist, including plasma exchange and intravenous immunoglobulin administration. Most cases may resolve without sequelae, but those that do not may leave behind significant persistent debility.

KEYWORDS:

Acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Acute motor axonal neuropathy; Demyelinating syndrome; Guillain-Barré syndrome; Miller Fisher syndrome

PMID:
25979580
DOI:
10.1016/j.pop.2015.01.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center